Literature DB >> 22364748

Approval of biosimilars in the USA--dead ringers?

.   

Abstract

Mesh:

Substances:

Year:  2012        PMID: 22364748     DOI: 10.1016/S0140-6736(12)60290-6

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

1.  Developing new drugs for diabetes and cardiometabolic disorders: a changing paradigm.

Authors:  Andrew J Krentz; Linda Morrow; Marcus Hompesch
Journal:  Drugs       Date:  2012-09-10       Impact factor: 9.546

2.  Innovation under Regulatory Uncertainty: Evidence from Medical Technology.

Authors:  Ariel Dora Stern
Journal:  J Public Econ       Date:  2016-11-23
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.